Salt Lake City, Utah-based Total Joint Orthopedics, Inc. (TJO), has completed the first cases with the Klassic Knee System’s PS-Max Tibial Insert at Salt Lake Regional Medical Center in Salt Lake City, Utah. TJO, already known for its streamlined surgery—only three trays per procedure—now has the PS-Max Tibial Insert so that surgeons can be afforded maximum stability for primary and revision cases.
Total Joint Orthopedics: New PS-MAX Tibial Insert
1 min read Premium comments
Secondary#klassickneesystem#totaljointorthopedics#bryantbonner#psmaxtibialinsert
Total Joint Orthopedics CEO Erin Hofmann told OTW, “The PS-Max continues our Evolution of Stability by protecting against post wear and providing additional varus/valgus and internal/external rotation constraint; transitioning from a primary to constrained knee is seamless and requires no additional steps, box prep or trays.”
“This is an exciting new addition to TJO’s offerings, providing more stability and constraint options for difficult cases, while using efficient instrument systems,” said Bryant E. Bonner, M.D. of Hofmann Arthritis Institute.
“Total Joint Orthopedics’ Klassic Knee System incorporates an innate efficiency and intuitive instrumentation to save sterilization cost and turnover time,” said the company. “Launched in 2013, the Klassic Knee System’s modern, universal knee design restores natural kinematic function. Accompanied by TJO’s unmatched Klassic ONE instrumentation, the Klassic Knee allows simplicity and ease of use with only one tray needed for up to 90% of surgeries (100% may be performed with two trays).”
“The PS-Max implant is a great addition to an already great system,” said Jason M. Jennings, M.D., D.P.T., from Colorado Joint Replacement. “TJO now provides me with the range of constraint options I need to tackle everything from a primary to complex primary total knee replacement.”
The newly reformulated PS-Post instrumentation offers ease of use and reduced waste, both in line with company goals. Also important to TJO is that procedures done with their implants support Operation Walk. In fact, the company continues to donate one implant for every ten sold.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.